温针灸局部配穴与局部远端配穴治疗乳腺癌相关淋巴水肿疗效比较:多中心随机对照试验研究方案
本研究为多中心、三臂平行、评估者盲法随机对照试验方案,拟纳入108例乳腺癌相关淋巴水肿患者,按等比例随机分为局部配穴组、局部远端配穴组和等待治疗组。局部配穴组与局部远端配穴组分别接受8周共20次温针灸治疗,主要结局为第8周时患健侧臂围差均值较基线的变化。研究旨在验证温针灸治疗乳腺癌相关淋巴水肿的有效性,并比较两种配穴方案的疗效差异。
要点
- 温针灸可能改善乳腺癌相关淋巴水肿,本研究采用三臂随机对照设计验证其疗效
- 局部配穴与局部远端配穴两种方案将在8周内各接受20次温针灸治疗
- 主要结局为第8周患健侧臂围差均值较基线的变化
核心结论
- 研究旨在验证温针灸治疗乳腺癌相关淋巴水肿的有效性,并比较局部配穴与局部远端配穴两种方案的疗效差异。
研究设计与样本
- 多中心、三臂平行、评估者盲法、随机对照试验方案,拟纳入108例确诊乳腺癌相关淋巴水肿的受试者。
- 受试者按等比例随机分配至局部配穴组、局部远端配穴组或等待治疗组,每组各36例(按108例等比例推算)。
主要发现
- 局部配穴组与局部远端配穴组分别接受局部配穴组合与局部远端配穴组合的温针灸治疗,8周内共20次。
- 等待治疗组在研究结束后接受温针灸治疗。
- 主要结局为第8周患健侧臂围差均值较基线的变化,次要结局包括体积测量、皮肤硬度、常见不良事件术语标准4.03版水肿肢体标准、国际淋巴学会淋巴水肿分期、臂肩手功能障碍问卷及SF-36健康调查。
关键数值与推荐
- 主要结局指标为第8周时患健侧臂围差均值较基线的变化。
- 次要结局包括体积测量、皮肤硬度、CTCAE 4.03水肿肢体标准、国际淋巴学会淋巴水肿分期、DASH问卷和SF-36。
临床怎么用
- 该方案若验证有效,可为乳腺癌相关淋巴水肿提供温针灸治疗选择,并指导局部配穴与局部远端配穴的临床选用。
局限性
- 本文为研究方案,尚未报告温针灸治疗乳腺癌相关淋巴水肿的疗效数据。
- 等待治疗组在研究结束后才接受治疗,可能存在伦理与随访偏倚考量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lymphedema is the most common complication after breast cancer treatment, but management of lymphedema remains a clinical challenge. Several studies have reported the beneficial effect of acupuncture for treating breast cancer-related lymphedema (BCRL). Our objective is to verify the effectiveness of warm acupuncture on BCRL and compare the effectiveness of a local distribution acupoint combination with a local-distal acupoint combination for BCRL. METHODS: This is a study protocol for a multicenter, three-arm parallel, assessor blinded, randomized controlled trial. A total of 108 participants diagnosed as BCRL will be randomly allocated in equal proportions to a local distribution acupoint (LA) group, a local-distal acupoint (LDA) group, or a waiting-list (WL) group. The LA and LDA groups will receive 20 acupuncture treatment over 8 weeks with local distribution acupoint combination and local-distal acupoint combination, respectively. The WL group will receive acupuncture treatment after the study is concluded. The primary outcome is the mean change in inter-limb circumference difference from baseline to week 8. The secondary outcomes include volume measurement, skin hardness, common terminology criteria for adverse events 4.03 (edema limbs criteria), stages of lymphedema from the International Society of Lymphology, Disabilities of the Arm, Shoulder and Hand questionnaire, and the Medical Outcome Study 36-item Short-form Health Survey. DISCUSSION: This study aims to provide data on warm acupuncture as an effective treatment for BCRL and at the same time compare the effectiveness of different acupoint combinations. TRIAL REGISTRATION: ClinicalTrials.gov: Identifier NCT03373474 . Registered on 14th December 2017.
引用
- Yeh CH, Zhao TY, Zhao MD, et al. Comparison of effectiveness between warm acupuncture with local-distal points combination and local distribution points combination in breast cancer-related lymphedema patients: a study protocol for a multicenter, randomized, controlled clinical trial. Trials. 2019. PMID: 31277678. doi:10.1186/s13063-019-3491-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。